货号 | 1326/10 |
别名 | 2,2-Bis[4-(2,3-epoxypropoxy)phenyl] |
供应商 | Tocris |
生物活性 | PPARγ pure antagonist with micromolar affinity in 3T3-L1 and 3T3-F442A preadipocyte cells; selective over PPARδ and PPARα. Antagonizes the ability of rosiglitazone to stimulate transcriptional activity of PPARγ. Acts as a PPARγ agonist in an ECV304 cell line. Also produces PPARγ-independent apoptosis of tumor cells via several mechanisms. Active in vivo. |
运输条件 | Blue Ice |
存放说明 | -20℃ |
纯度 | >95 % |
计算分子量 | 340.42 |
分子式 | C21H24O4 |
可溶性/溶解性 | Soluble to 50 mM in ethanol and to 100 mM in DMSO |
CAS号 | 1675-54-3 |
参考文献 | Cuzzocreaet al (2004) Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation. Eur.J.Pharmacol. 483 79. PMID: 14709329. Fehlberget al (2003) Bisphenol A diglycidyl ether-induced apoptosis involves Bax/Bid-dependent mitochondrial release of apoptosis-inducing factor (AIF), cytochrome c and Smac/DIABLO. Br.J.Pharmacol. 139 495. PMID: 12788809. Bishop-Baileyet al (2000) Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line. Br.J.Pharmacol. 131 651. PMID: 11030710. Wrightet al (2000) A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation. J.Biol.Chem. 275 1873. PMID: 10636887. |